Indian Journal of Dermatology
  Publication of IADVL, WB
  Official organ of AADV
Indexed with Science Citation Index (E) , Web of Science and PubMed
Users online: 2179  
Home About  Editorial Board  Current Issue Archives Online Early Coming Soon Guidelines Subscriptions  e-Alerts    Login  
    Small font sizeDefault font sizeIncrease font size Print this page Email this page

    Article Cited by others


Efficacy and safety of topical halometasone in eczematous dermatoses in Indian population: An open label, noncomparative study

Jerajani H R, Kumar A S, Kuruvila Maria, Nataraja H V, Philip Mariam, Pratap D V S, Sumathy T K, Krishnankutty Binny, Dhawan Shilpi, Thomas Dennis

Year : 2011| Volume: 56| Issue : 6 | Page no: 652-656

   This article has been cited by
1 Halometasone 0.05% cream in eczematous dermatoses the execare working group
Jadhav, S., Srivastava, S., Visakhapatnam, G.P.P., (...), Thangasaravananan, P., Dhawan, S.
Journal of Clinical and Aesthetic Dermatology. 2013;
[Pubmed]  [Google Scholar]
2 Evaluation of efficacy, safety, and tolerability of fixed dose combination (FDC) of halometasone 0.05% and fusidic acid 2% w/w topical cream versus FDC of betamethasone valerate 0.12% and neomycin sulphate 0.5% w/w topical cream in the treatment of infected eczematous dermatosis in Indian subjects: A randomized open-label comparative phase III multi-centric trial
Pratap, D.V.S., Philip, M., Rao, N.T., Jerajani, H.R., Kumar, S.A., Kuruvila, M., Moodahadu, L.S., Dhawan, S.
Indian Journal of Dermatology. 2013; 58(2): 117-123
[Pubmed]  [Google Scholar]


Read this article